Skip to main content

Migraine News (Page 5)

Related terms: Migraine Headache, Hemiplegic Migraine, Complicated Migraine, Basilar-Type Migraine, Basilar Artery Migraine

NuPathe's Zecuity Approved by the FDA for the Acute Treatment of Migraine

CONSHOHOCKEN, PA--(Marketwire - Jan 17, 2013) - NuPathe Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Zecuity (sumatriptan iontophoretic transdermal system) for...

FDA Approves Botox to Treat Chronic Migraine

SILVER SPRING, Md., Oct. 15 – The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine...

FDA Medwatch Alert: Ergotamine tartrate

[Posted 03/02/2007] FDA informed healthcare professionals and consumers that the Agency ordered twenty firms to stop marketing unapproved drug products containing ergotamine tartrate. Ergotamine...

FDA Medwatch Alert: 5-Hydroxytryptamine Receptor Agonists (Triptans) - Serotonin Syndrome

[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Migraine Prevention, Migraine Prophylaxis, Chronic Migraine, Headache

Related drug support groups

gabapentin, ibuprofen, amitriptyline, venlafaxine, propranolol, diclofenac, cyclobenzaprine, topiramate, sumatriptan, view more... Excedrin, Imitrex, Excedrin Migraine, Ubrelvy, erenumab, cyproheptadine, verapamil, Migraine Relief